Incyte Corp. (INCY)
123.22
-1.15
(-0.92%)
USD |
NASDAQ |
Aug 31, 16:00
123.19
-0.03
(-0.02%)
After-Hours: 20:00
Incyte Total Long Term Debt (Quarterly) : 32.68M for June 30, 2026
Total Long Term Debt (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 32.68M |
| March 31, 2026 | 33.83M |
| December 31, 2025 | 49.22M |
| September 30, 2025 | 35.37M |
| June 30, 2025 | 36.24M |
| March 31, 2025 | 37.12M |
| December 31, 2024 | 54.75M |
| September 30, 2024 | 32.16M |
| June 30, 2024 | 32.62M |
| March 31, 2024 | 32.61M |
| December 31, 2023 | 46.88M |
| September 30, 2023 | 31.92M |
| June 30, 2023 | 32.66M |
| March 31, 2023 | 32.85M |
| December 31, 2022 | 47.37M |
| September 30, 2022 | 33.59M |
| June 30, 2022 | 34.19M |
| March 31, 2022 | 34.18M |
| December 31, 2021 | 49.88M |
| September 30, 2021 | 48.73M |
| June 30, 2021 | 49.75M |
| March 31, 2021 | 47.66M |
| December 31, 2020 | 49.04M |
| September 30, 2020 | 60.15M |
| June 30, 2020 | 65.65M |
| Date | Value |
|---|---|
| March 31, 2020 | 62.54M |
| December 31, 2019 | 62.74M |
| September 30, 2019 | 63.90M |
| June 30, 2019 | 63.58M |
| March 31, 2019 | 31.81M |
| December 31, 2018 | 17.43M |
| September 30, 2018 | 17.22M |
| June 30, 2018 | 17.02M |
| March 31, 2018 | 16.81M |
| December 31, 2017 | 16.61M |
| September 30, 2017 | 23.71M |
| June 30, 2017 | 23.43M |
| March 31, 2017 | 41.60M |
| December 31, 2016 | 651.48M |
| September 30, 2016 | 643.43M |
| June 30, 2016 | 635.49M |
| March 31, 2016 | 627.64M |
| December 31, 2015 | 619.89M |
| September 30, 2015 | 623.93M |
| June 30, 2015 | 659.96M |
| March 31, 2015 | 697.55M |
| December 31, 2014 | 689.12M |
| September 30, 2014 | 730.21M |
| June 30, 2014 | 673.32M |
| March 31, 2014 | 665.22M |
Total Long Term Debt Definition
Represents a company's total debt maturing for more than 12 months of the reporting period.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| Mirum Pharmaceuticals, Inc. | 760.54M |
| Regeneron Pharmaceuticals, Inc. | 2.707B |
| Eli Lilly & Co. | 49.62B |
| AbbVie, Inc. | 70.82B |
| Biogen, Inc. | 8.355B |